Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Mycoses 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Neutropenia 1Myelodysplastic Syndromes 1Leukemia 1Invasive Fungal Infections 1Glioblastoma 1Bronchiolitis Obliterans Syndrome 1Brain Neoplasms 1Bone Marrow Neoplasms 1

Interventions

Voriconazole 3posaconazole 2Fluconazole 2Caspofungin 2liposomal amphotericin B 1Standard of Care 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Cyclosporine 1Antilymphocyte Serum 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Mycoses × posaconazole × Clear all
NCT00936117 2019-02-27

Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Mycoses, Bone Marrow Neoplasms

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed
75 enrolled 14 charts
Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡